Placebo-surgery controlled trials

High-quality, trustworthy evidence on established clinical practices is obviously essential, but not enough: one needs to make a conscious effort to ensure that the research has practical impact –eliciting a change in the way medicine is practiced around the world!

FIDELITY was considered the key evidence by the Council for Choices in Health Care in Finland (COHERE, a permanent body appointed by the Government that works in conjunction with the Ministry of Social Affairs and Health) in making a rare restrictive funding decision; COHERE declared in 2017 that knee arthroscopy for degenerative knee disease will no longer be included in the range of public health services available in Finland 1.

Possibly even more noteworthy, in the same year, the BMJ RapidRec panel issued a guideline that made a strong recommendation against the use of arthroscopy in nearly all patients with degenerative knee disease 2. The panel went further to recommend that healthcare administrators and funders may use the number of arthroscopies performed in patients with degenerative knee disease as an indicator of poor quality care.  It is possible that knee arthroscopy could be considered one of the starkest examples of modern medical reversal.

We just published the FIMPACT trial, so it is too early to say anything about its’ practical impact, but stay tuned, in 2-3 years, we should be able to comment on that, too.

Where are we now?
The funders seem to be reacting to the mounting evidence on various procedures being shown to be marginally effective or “low value care”. Subacromial decompression and knee arthroscopies for arthritis are among an initial list of 17 operations that will be discontinued completely or highly restricted by NHS England:

https://www.bbc.com/news/health-44665560

https://www.theguardian.com/society/2018/jun/29/nhs-wields-the-axe-on-17-unnecessary-procedures

One way to consider this is that in less than 50 years, the use of arthroscopic surgery for knee and shoulder pain went from new techniques to widespread clinical practices, to be utterly rejected. As such, they would mark one of the most staggering examples of Scott’s parabola 3 in medicine (below):

 

    1. A statement on knee arthroscopy for degenerative knee disease by the Council for Choices in Health Care in Finland, Government appointed council working in conjunction with the Finnish Ministry of Social Affairs and Health. http://palveluvalikoima.fi/en/recommendations (accessed May 25, 2017).
    2. Siemieniuk RAC, Harris IA, Agoritsas T, et al. Arthroscopic surgery for degenerative knee arthritis and meniscal tears: a clinical practice guideline. Bmj 2017;357:j1982. doi: 10.1136/bmj.j1982
    3. Scott JW. Scott’s parabola: the rise and fall of a surgical technique. British Med J 2001;323(1477) doi: 10.1136/bmj.323.7327.1477

Principal investigators

Teppo Järvinen

Professor, Head

Simo Taimela

Adjunct professor, Research director

Publications

Raine Sihvonen, Mika Paavola, Antti Malmivaara, Ari Itälä, Antti Joukainen, Heikki Nurmi, Juha Kalske, Anna Ikonen, Timo Järvelä, Tero Järvinen, Kari Kanto, Janne Karhunen, Jani Knifsund, Heikki Kröger, Tommi Kääriäinen, Janne Lehtinen, Jukka Nyrhinen, Juha Paloneva, Outi Päiväniemi, Marko Raivio, Janne Sahlman, Roope Sarvilinna, Sikri Tukiainen, Ville-Valtteri Välimäki, Ville Äärimaa, Pirjo Toivonen, Teppo Järvinen